Literature DB >> 18173327

Transsphenoidal surgery in a patient with acromegaly and McCune-Albright syndrome: application of neuronavigation.

Wanchen Dou1, Ning Lin, Wenbin Ma, Yi Yang, Huijuan Zhu, Juan Sun, Wei Lian, Zhong Yang, Wuyi Li, Renzhi Wang.   

Abstract

The McCune-Albright syndrome (MAS) is characterized by a clinical triad of polyostotic fibrous dysplasia, café-au-lait hyperpigmented macules, and hypersecretory endocrinopathies. Acromegaly is an uncommon manifestation of the endocrine disturbance associated with MAS, and the role of surgery in managing these cases has been a topic of debate. The authors present the case of a 35-year-old man with MAS who was also diagnosed with acromegaly, hyperprolactinemia, and pituitary macroadenoma. The patient had an 18-year history of fibrous dysplasia involving the right frontal bone and ribs as well as multiple endocrinopathies, but no cutaneous hyperpigmented macules. An oral glucose tolerance test demonstrated partial suppression of plasma levels of growth hormone (GH). The patient underwent transsphenoidal resection of the pituitary tumor, performed with assistance of neuronavigation, and tolerated the procedure well. After the surgery, both prolactin and GH levels returned to normal. These results suggest that neuronavigation-assisted transsphenoidal surgery can safely remove pituitary adenomas associated with MAS and successfully treat the underlying endocrine abnormalities.

Entities:  

Mesh:

Year:  2008        PMID: 18173327     DOI: 10.3171/JNS/2008/108/01/0164

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  McCune-Albright syndrome: surgical and therapeutic challenges in GH-secreting pituitary adenomas.

Authors:  Helen Madsen; Manuel Thomas Borges; Janice M Kerr; Kevin O Lillehei; B K Kleinschmidt-Demasters
Journal:  J Neurooncol       Date:  2010-11-21       Impact factor: 4.130

Review 2.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

3.  Transsphenoidal approach for pituitary adenomas in patients with McCune-Albright syndrome.

Authors:  Wanchen Dou; Xiao Di; Renzhi Wang; Huijuan Zhu; Yong Yao; Kan Deng; Ming Feng; Guilin Li; Junji Wei
Journal:  Pituitary       Date:  2013-06       Impact factor: 4.107

4.  Endoscopic Decompression for Optic Neuropathy in McCune-Albright Syndrome.

Authors:  Jung-Hoon Noh; Doo-Sik Kong; Ho Jun Seol; Hyung Jin Shin
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

5.  Treatment protocols for growth hormone-secreting pituitary adenomas combined with craniofacial fibrous dysplasia: A case report of atypical McCune-Albright syndrome.

Authors:  Jia Xu; Xi Li; Chang-Sheng Lv; Ying Chen; Meng Wang; Jian-Feng Liu; Lai Gui
Journal:  Exp Ther Med       Date:  2014-06-19       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.